Merck KGaA (OTCMKTS:MKKGY - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $27.19 and last traded at $27.23, with a volume of 47833 shares traded. The stock had previously closed at $28.26.
Merck KGaA Trading Up 1.7 %
The stock has a 50 day moving average of $29.13 and a 200 day moving average of $30.89. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91. The firm has a market cap of $18.24 billion, a P/E ratio of 17.43, a PEG ratio of 2.05 and a beta of 0.98.
Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. The firm had revenue of $5.78 billion for the quarter, compared to analyst estimates of $5.40 billion. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. As a group, equities research analysts predict that Merck KGaA will post 1.87 EPS for the current year.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
